Owner AstraZeneca AB

Inventors Hummersone, Marc Geoffrey; Javaid, Muhammad Hashim; Lence, Carlos Fenandez; Menear, Keith Allan; Roberts, Craig Anthony; Blades, Kevin; Gomez, Sylvie; Martin, Niall Morrison Barr; Rudge, David Alan

Agent Shelston IP

Pub. Number AU-A-2009207498

PCT Pub. Number WO2009/093032

Priority 61/022,900 23.01.08 US; 61/142,413 05.01.09 US

Filing date 23 January 2009

Wipo publication date 30 July 2009

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or